General Information of the Compound
| Compound ID |
CP0551527
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(3aS,4R,9S,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl]-2,4-bis(trifluoromethyl)benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C18H19F6N7O4
|
||||||||||||||||||
| Molecular Weight |
511.383
|
||||||||||||||||||
| Canonical SMILES |
OC[C@@H]1NC(=N)N2C[C@H](NC(=O)c3ccc(cc3C(F)(F)F)C(F)(F)F)C(O)(O)[C@@]22NC(=N)N[C@@H]12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C18H19F6N7O4/c19-17(20,21)6-1-2-7(8(3-6)18(22,23)24)12(33)28-10-4-31-14(26)27-9(5-32)11-15(31,16(10,34)35)30-13(25)29-11/h1-3,9-11,32,34-35H,4-5H2,(H2,26,27)(H,28,33)(H3,25,29,30)/t9-,10-,11-,15-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LPJFOYUXGSRSAK-VEABSNGSSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03043, Sodium channel protein type 4 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha